Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.

Teirstein PS, Meredith IT, Feldman RL, Rabinowitz AC, Cannon LA, Lee TC, Dens J, Dubois CL, Mooney MR, Pompili VJ, Saito S, Allocco DJ, Dawkins KD, Stone GW.

Catheter Cardiovasc Interv. 2014 Jun 6. doi: 10.1002/ccd.25565. [Epub ahead of print]

PMID:
24905795
[PubMed - as supplied by publisher]
2.

Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial).

Meredith IT, Teirstein PS, Bouchard A, Carrié D, Möllmann H, Oldroyd KG, Hall J, Allocco DJ, Dawkins KD, Stone GW.

Am J Cardiol. 2014 Apr 1;113(7):1117-23. doi: 10.1016/j.amjcard.2013.12.011. Epub 2014 Jan 14.

PMID:
24530167
[PubMed - indexed for MEDLINE]
3.

Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents.

Saito S, Hagiwara N, Seki A, Igarashi K, Muramatsu T, Yajima J, Yokoi H, Nakamura M, Fujii K, Isshiki T, Stone GW, Teirstein PS, Meredith IT, Allocco DJ, Dawkins KD.

J Cardiol. 2014 Aug;64(2):105-12. doi: 10.1016/j.jjcc.2013.12.003. Epub 2014 Jan 23.

PMID:
24462183
[PubMed - in process]
4.

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.

Meredith IT, Worthley SG, Whitbourn RJ, Antonis P, Montarello JK, Newcomb AE, Lockwood S, Haratani N, Allocco DJ, Dawkins KD.

EuroIntervention. 2014 Mar 20;9(11):1264-70. doi: 10.4244/EIJV9I11A216.

PMID:
24169077
[PubMed - in process]
Free Article
5.

Boston Scientific Lotus valve.

Meredith IT, Hood KL, Haratani N, Allocco DJ, Dawkins KD.

EuroIntervention. 2012 Sep;8 Suppl Q:Q70-4. doi: 10.4244/EIJV8SQA12.

PMID:
22995115
[PubMed - indexed for MEDLINE]
6.

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Meredith IT, Verheye S, Weissman NJ, Barragan P, Scott D, Valdés Chávarri M, West NE, Kelbæk H, Whitbourn R, Walters DL, Kubica J, Thuesen L, Masotti M, Banning A, Sjögren I, Stables RH, Allocco DJ, Dawkins KD.

EuroIntervention. 2013 Jul;9(3):308-15. doi: 10.4244/EIJV9I3A52.

PMID:
23872647
[PubMed - indexed for MEDLINE]
Free Article
7.

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Meredith IT, Verheye S, Weissman NJ, Barragan P, Scott D, Chávarri MV, West NE, Kelbæk H, Whitbourn R, Walters DL, Kubica J, Thuesen L, Masotti M, Banning A, Sjögren I, Stables RH, Allocco DJ, Dawkins KD.

EuroIntervention. 2013 May 22. pii: 20130416-02. [Epub ahead of print]

PMID:
23688934
[PubMed - as supplied by publisher]
8.

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials.

Kereiakes DJ, Popma JJ, Cannon LA, Kandzari DE, Kimmelstiel CD, Meredith IT, Teirstein PS, Verheye S, Allocco DJ, Dawkins KD, Stone GW.

EuroIntervention. 2012 Jun 20;8(2):187-95. doi: 10.4244/EIJV8I2A32.

PMID:
22445912
[PubMed - indexed for MEDLINE]
Free Article
9.

Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.

Meredith IT, Verheye S, Dubois CL, Dens J, Fajadet J, Carrié D, Walsh S, Oldroyd KG, Varenne O, El-Jack S, Moreno R, Joshi AA, Allocco DJ, Dawkins KD.

J Am Coll Cardiol. 2012 Apr 10;59(15):1362-70. doi: 10.1016/j.jacc.2011.12.016. Epub 2012 Feb 15.

PMID:
22341736
[PubMed - indexed for MEDLINE]
Free Article
10.

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.

Meredith IT, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone GW, Teirstein PS, Starzyk RM, Allocco DJ, Dawkins KD.

EuroIntervention. 2011 May;7(1):84-90. doi: 10.4244/EIJV7I1A15.

PMID:
21550907
[PubMed - indexed for MEDLINE]
Free Article
11.

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD; PLATINUM Trial Investigators.

J Am Coll Cardiol. 2011 Apr 19;57(16):1700-8. doi: 10.1016/j.jacc.2011.02.016. Epub 2011 Apr 4.

PMID:
21470815
[PubMed - indexed for MEDLINE]
Free Article
12.

Everolimus-eluting stents: update on current clinical studies.

Allocco DJ, Joshi AA, Dawkins KD.

Med Devices (Auckl). 2011;4:91-8. doi: 10.2147/MDER.S22043. Epub 2011 Jul 26.

PMID:
22915935
[PubMed]
Free PMC Article
13.

Express LD vascular stent in the treatment of iliac artery lesions: 24-month results from the MELODIE trial.

Stockx L, Poncyljusz W, Krzanowski M, Schroë H, Allocco DJ, Dawkins KD; MELODIE Investigators.

J Endovasc Ther. 2010 Oct;17(5):633-41. doi: 10.1583/09-2917MR.1.

PMID:
20939723
[PubMed - indexed for MEDLINE]
14.

Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).

Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, Fiocca L, Matiashvili A, Lortkipanidze N, Vassileva A, Popma JJ, Allocco DJ, Dawkins KD, Valsecchi O, Costa MA.

Circ Cardiovasc Interv. 2010 Aug;3(4):367-75. doi: 10.1161/CIRCINTERVENTIONS.110.950154. Epub 2010 Jul 20.

PMID:
20647562
[PubMed - indexed for MEDLINE]
Free Article
15.

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent.

Ormiston JA, Lefèvre T, Grube E, Allocco DJ, Dawkins KD.

EuroIntervention. 2010 May;6(1):46-53. doi: 10.4244/.

PMID:
20542797
[PubMed - indexed for MEDLINE]
16.

Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial.

Hopkins LN, Myla SV, Grube E, Eles G, Dave R, Jaff MR, Allocco DJ.

EuroIntervention. 2010 Apr;5(8):917-24. doi: 10.4244/.

PMID:
20542776
[PubMed - indexed for MEDLINE]
17.

A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.

Grube E, Schofer J, Hauptmann KE, Nickenig G, Curzen N, Allocco DJ, Dawkins KD.

JACC Cardiovasc Interv. 2010 Apr;3(4):431-8. doi: 10.1016/j.jcin.2009.12.015.

PMID:
20398872
[PubMed - indexed for MEDLINE]
Free Article
18.

A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program.

Allocco DJ, Cannon LA, Britt A, Heil JE, Nersesov A, Wehrenberg S, Dawkins KD, Kereiakes DJ.

Trials. 2010 Jan 7;11:1. doi: 10.1186/1745-6215-11-1.

PMID:
20059766
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events.

Leon MB, Allocco DJ, Dawkins KD, Baim DS.

JACC Cardiovasc Interv. 2009 Jun;2(6):504-12. doi: 10.1016/j.jcin.2009.04.004.

PMID:
19539253
[PubMed - indexed for MEDLINE]
Free Article
20.

Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial.

Hopkins LN, Myla S, Grube E, Wehman JC, Levy EI, Bersin RM, Joye JD, Allocco DJ, Kelley L, Baim DS.

Catheter Cardiovasc Interv. 2008 Jun 1;71(7):950-60. doi: 10.1002/ccd.21564.

PMID:
18412236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk